The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study to assess the safety of neoadjuvant trifluridine/tipiracil with concurrent radiation in resectable stage II/III rectal cancer.
 
Emerson Yu-sheng Chen
Other Relationship - Horizon CME; Taiho Pharmaceutical
 
Nima Nabavizadeh
No Relationships to Disclose
 
Daniel Herzig
No Relationships to Disclose
 
Elena Korngold
No Relationships to Disclose
 
Adel Kardosh
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Eisai; Exelixis; Exelixis; Genentech
Research Funding - Natera
 
Guillaume Joe Pegna
Stock and Other Ownership Interests - Amryt Pharma
 
Kenneth Gregory Bensch
No Relationships to Disclose
 
Eric C. Anderson
Consulting or Advisory Role - Aileron Therapeutics; Roche/Genentech
Travel, Accommodations, Expenses - Aileron Therapeutics
 
Vassiliki Liana Tsikitis
No Relationships to Disclose
 
Kim Lu
No Relationships to Disclose
 
Skye C. Mayo
No Relationships to Disclose
 
Brian Brinkerhoff
No Relationships to Disclose
 
Shaun Goodyear
Consulting or Advisory Role - PDX Pharmacy
 
Melissa Wong
No Relationships to Disclose
 
Anne Fahlman
No Relationships to Disclose
 
Erin Taber
No Relationships to Disclose
 
Johnson Vo
No Relationships to Disclose
 
Charles R. Thomas
Employment - AMA
Consulting or Advisory Role - AMA; F3 Platform Biologics
 
Charles D. Lopez
Research Funding - Roche/Genentech (Inst); Taiho Pharmaceutical